Sign In
Buy CCXI
$13.86
-0.140 (-1.00%)
At Close: Jul 31, 2026
Charles Schwab Investment Management Inc. Grows Stock Holdings in ChemoCentryx Inc (NASDAQ:CCXI)
10:08am, Sunday, 15'th Mar 2020
Charles Schwab Investment Management Inc. boosted its position in ChemoCentryx Inc (NASDAQ:CCXI) by 3.7% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 100,310 sh
SVB Leerink Reaffirms Outperform Rating for ChemoCentryx (NASDAQ:CCXI)
06:30am, Sunday, 15'th Mar 2020
SVB Leerink reiterated their outperform rating on shares of ChemoCentryx (NASDAQ:CCXI) in a research report sent to investors on Wednesday, Zacks.com reports. Several other brokerages also recently is
ChemoCentryx Inc (NASDAQ:CCXI) Forecasted to Post Q1 2020 Earnings of ($0.30) Per Share
05:32am, Saturday, 14'th Mar 2020
ChemoCentryx Inc (NASDAQ:CCXI) – Investment analysts at Piper Sandler issued their Q1 2020 earnings per share (EPS) estimates for shares of ChemoCentryx in a report issued on Tuesday, March 10th. Pi
Edited Transcript of GALNA.S earnings conference call or presentation 12-Mar-20 1:00pm GMT
11:23pm, Thursday, 12'th Mar 2020
Full Year 2019 Vifor Pharma AG Earnings Call
Breathe - Here Are The Best Stocks To Buy Now
06:50pm, Thursday, 12'th Mar 2020
Markets are scary, but chasing returns is a losing strategy. Stocks are oversold, but margin remains a sharp-edged blade. Here are the top sectors and stocks no
ChemoCentryx, Inc. Just Reported Full-Year Earnings And Analysts Are Lifting Their Estimates
11:00am, Thursday, 12'th Mar 2020
There's been a notable change in appetite for ChemoCentryx, Inc. (NASDAQ:CCXI) shares in the week since its full-year...
Earnings Update: ChemoCentryx, Inc. Just Reported And Analysts Are Boosting Their Estimates
10:52am, Thursday, 12'th Mar 2020
There's been a notable change in appetite for ChemoCentryx, Inc. (NASDAQ:CCXI) shares in the week since its full-year...
J.P. Morgan Sticks to Its Buy Rating for ChemoCentryx (CCXI)
06:07pm, Wednesday, 11'th Mar 2020
In a report released today, Anupam Rama from J.P. Morgan maintained a Buy rating on ChemoCentryx (CCXI), with a price target of $61.00. The company's
J.P. Morgan Sticks to Its Buy Rating for ChemoCentryx (CCXI)
06:07pm, Wednesday, 11'th Mar 2020
In a report released today, Anupam Rama from J.P. Morgan maintained a Buy rating on ChemoCentryx (CCXI – Research Report),
ChemoCentryx price target raised to $64 from $56 at Raymond James CCXI
11:41am, Wednesday, 11'th Mar 2020
ChemoCentryx price target raised to $64 from $56 at Raymond James Raymond James CCXI
Analysts Offer Insights on Healthcare Companies: ChemoCentryx (CCXI), Crinetics Pharmaceuticals (CRNX) and Trillium Therapeutics (TRIL)
11:14am, Wednesday, 11'th Mar 2020
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on ChemoCentryx (CCXI), Crinetics Pharmaceuticals (CRNX) and
